<DOC>
	<DOCNO>NCT00303381</DOCNO>
	<brief_summary>The purpose study determine safety efficacy interferon-beta-1a subject active ulcerative colitis ( UC ) .</brief_summary>
	<brief_title>Safety Efficacy Interferon-Beta-1a ( Rebif® ) Treating Subjects With Acute Symptoms Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-beta</mesh_term>
	<mesh_term>Interferon beta-1a</mesh_term>
	<criteria>Moderately active UC , define : Diagnosis UC document clinical , radiological endoscopic histological finding Proctosigmoidoscopic diagnosis : least leftsided disease ; extent colonic inflammation 20 centimeter anal verge A flare disease activity consider moderate accord UCSS 14 day initiation study medication . Moderate disease define UCSS 6 10 UCSS Physician 's Global Assessment le ( &lt; ) 3 proctosigmoidoscopy score 2 3 At least one previous flareup UC Maintenance treatment 5aminosalicylic acid ( 5ASA ) stable dose management UC allow , require . The daily dose 5ASA stable least 4 week Study Day 1 3.6 gram/day . This dose maintain throughout study . Corticosteroids allow study , exception inhale steroid topical dermatological steroid Age ≥18 year , either sex Adequate bone marrow reserve : white blood cell ( WBC ) great ( &gt; ) 3.5*10^9 per liter ( /L ) , neutrophils &gt; 1.5*10 ^9 /L , thrombocytes &gt; 100 *10^9 /L , hemoglobin &gt; 8.5 gram per deciliter ( g/dL ) Female subject neither pregnant breastfeeding lack childbearing potential , define either postmenopausal surgically sterile use hormonal contraceptive , intrauterine device , diaphragm spermicide pregnant establish negative serum urinary Human chorionic gonadotrophin ( hCG ) test within 7 day Study Day 1 . A pregnancy test require subject postmenopausal surgically sterile Willingness ability comply protocol duration study Written inform consent , obtain studyrelated procedure part subject 's normal medical care , understand subject withdraw consent time without prejudice future medical care Previous systemic treatment interferon , immunosuppressive therapy ( example [ e.g . ] , cyclosporin , azathioprine , 6mercaptopurine ) biological treatment ( e.g . anti Cluster differentiation [ CD ] 4 , antiCD5 , anti Tumour necrosis factor [ TNF ] alpha , Interleukin [ IL ] 10 ) 3 month Study Day 1 Any investigational drug experimental procedure 4 week Study Day 1 More three dos rectally administer 5ASA derivative 2 week Study Day 1 More two dos systemically rectally administer corticosteroid 14 day Study Day 1 Use nonsteroidal antiinflammatory drug ( NSAIDs ) antibiotic therapy ( e.g . metronidazole ) 2 week Study Day 1 Use codeine , narcotic , loperamide opiate Screening visit study Stool examination positive enteric pathogen , pathogenic ovum , parasite , Clostridium toxin Screening Need emergency surgery ( uncontrollable hemorrhage , persistent noninflammatory intestinal obstruction Investigator 's discretion perforation ) , elective surgery study , surgery 4 week study entry Inadequate liver function , define total bilirubin , aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) alkaline phosphatase level &gt; 2 time upper limit normal range Inadequate renal function , define serum creatinine &gt; 2.0 milligram per deciliter ( mg/dL ) Histopathological finding highgrade dysplasia history cancer ( except carcinoma situ cervix adequately treat basal cell squamous cell carcinoma skin ) Known allergy paracetamol ingredient medicinal product ( , active substance , human serum albumin mannitol ) Severe depressive disorder suicidal ideation , epilepsy history seizure adequately control treatment Known alcohol drug abuse within past 5 year Other serious concurrent systemic disorder incompatible study ( Investigator 's discretion ) Severe active infection ( Investigator 's discretion ) Dependence liquid diet</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>